Depression in the elderly linked to Alzheimer's risk

Molecular imaging study suggests late-life depression and beta-amyloid plaque in the brain could tip-off hastened development of the deadly dementia

2014-06-09

(Press-News.org) St. Louis, Mo. (June 9, 2014) – Many people develop depression in the latest stages of life, but until now doctors had no idea that it could point to a build up of a naturally occurring protein in the brain called beta-amyloid, a hallmark of Alzheimer's disease. In fact, late-life depression could become a major risk factor for developing Alzheimer's faster than others, according to research unveiled at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.

Alzheimer's disease is a currently incurable neurodegenerative disease with marked protein aggregates including beta-amyloid and tau. The disease begins developing years before noticeable cognitive decline and memory loss. Depression has been proven to have its own neurodegenerative effects on the brain, but here researchers have found an undeniable connection between beta-amyloid in depressed elderly patients with cognitive deficits and advancement to Alzheimer's disease. They were able to prove this using molecular imaging data from a global dementia imaging database.

"Our results clearly indicate that mild cognitively impaired subjects with depressive symptoms suffer from elevated amyloid-levels when compared with non-depressed individuals," said the study's principal scientist Axel Rominger, MD, from the department of nuclear medicine at the University of Munich in Germany. "The combination of elevated amyloid-levels and coexisting depressive symptoms constitute a patient population with a high risk for faster progression to Alzheimer's disease."

The study involved 371 patients with mild cognitive impairment who underwent PET imaging with the radiotracer F-18 florbetapir and magnetic resonance imaging (MRI) chosen retrospectively from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, which includes data from at least 55 research centers across the U.S. and Canada now readily available to more than 2,500 researchers worldwide. Results showed that mild cognitive impaired patients with depressive symptoms had higher amyloid deposition than non-depressed controls as indicated by the binding of the radiotracer to amyloid particularly in the frontal cortex and the anterior and posterior cingulate gyrus of the brain, both involved in mood disorders such as depression.

"Therapeutic options for Alzheimer's disease are still limited and therefore the identification and understanding of contributing risk factors that influence the disease are crucial in ongoing research as they offer the possibilities for future medical intervention," said co-author and fellow researcher Matthias Brendel. Additionally, knowing the risk could help patients make necessary lifestyle changes and prepare their families.

Alzheimer's disease is the most prevalent form of dementia. It is estimated that 44.4 million people are living with dementia worldwide. This number is expected to increase to approximately 75.6 million in 2030 and 135.5 million in 2050, according to 2013 data from the Alzheimer's Disease International.

INFORMATION: Scientific Paper 87: Matthias Brendel, Eva Kalinowski, Andreas Delker, Peter Bartenstein, Axel Rominger, Dept. of Nuclear Medicine, University of Munich, Munich, Germany, "Subsyndromal late life depression is associated with amyloid accumulation in mild cognitive impairment," SNMMI's 61th Annual Meeting, June 7, 2014, St. Louis, Missouri.

About the Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.

SNMMI's more than 18,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit http://www.snmmi.org.

ELSE PRESS RELEASES FROM THIS DATE:

REM sleep disturbance signals future neurodegenerative disease

2014-06-09

St. Louis, Mo. (June 9, 2014) – How many millions of people suffer from sleep disturbance? One sleep disorder in particular, called REM behavior disorder, could be a sign of impending neurodegenerative disease, including Parkinson's and dementia, say scientists presenting their research at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting. Researchers are not sure why spontaneous and unexplained disturbance in REM sleep should lead to a neurodegenerative disease like Parkinson's, but new longitudinal imaging data show a clear correlation between ...

A few circulating cancer cells could cue risk of metastases

2014-06-09

St. Louis, Mo. (June 9, 2014) – A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients' chances of survival, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting. Metastasis accounts for an estimated 90 percent of cancer deaths. For decades, researchers tried to develop a way to gauge a cancer's risk of metastasizing from a blood sample—the long-sought-after liquid biopsy. Today there are numerous methods available to isolate lone cells. ...

Molecular imaging finds novel way to knock down breast cancer

2014-06-09

St. Louis, Mo. (June 9, 2014) – For years researchers have been developing molecular imaging techniques that visualize hormonally active breast cancer cells—specifically those testing positive for human epidermal growth factor receptor 2 (HER2). A recent innovation in breast cancer biomarkers seeks the HER3 receptor instead, which could mean more comprehensive breast cancer imaging and potential treatments, say experts presenting data during the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting. Breast cancer is one of the most prevalent forms of ...

PSMA-based imaging traces even treatment-resistant prostate cancer

2014-06-09

St. Louis, Mo. (June 9, 2014) – Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized—but some cases simply do not respond to this treatment. A groundbreaking molecular imaging agent has been developed to help clinicians find as much cancer as possible, whether it is responding favorably or not, in an effort to improve clinical decision making for these patients, say researchers at the Society of Nuclear ...

Molecular breast imaging protocol unmasks more cancer

2014-06-09

St. Louis, Mo. (June 9, 2014) – Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m filtered sulfur colloid when undergoing lymphoscintigraphy, a functional imaging technique that scouts new cancer as it begins to metastasize. Best results also indicate that imaging could be improved by injecting the agent the day prior to surgical resection, according to research unveiled at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting. "The innovative ...

Presurgical SPECT/CT shows more cancer than current standard

2014-06-09

St. Louis, Mo. (June 9, 2014) – Startling data from an international multi-center trial provide growing evidence that sentinel node imaging is more effectively accomplished with hybrid functional imaging with single photon emission computed tomography and computed tomography (SPECT/CT) than with another molecular imaging technique called lymphoscintigraphy. This conclusion held after imaging a range of cancers displaying a variety of lymphatic drainage types associated with melanoma, an aggressive skin cancer; breast carcinoma; and malignancies of the pelvis, such as prostate ...

Connecting dead ends increases power grid stability

2014-06-09

Climate change mitigation strategies such as the German Energiewende require linking vast numbers of new power generation facilities to the grid. As the input from many renewable sources is rather volatile, depending on how much the wind blows or the sun shines, there's a higher risk of local power instabilities and eventually blackouts. Scientists from the Potsdam Institute for Climate Impact Research (PIK) now employed a novel concept from nonlinear systems analysis called basin stability to tackle this challenge. They found that connecting dead ends can significantly ...

Einstein & Montefiore present research at American Diabetes Association Scientific Sessions

2014-06-09

June 9, 2014 – (BRONX, NY) – Investigators at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center will present their latest research at the American Diabetes Association's 74th Scientific Sessions. Einstein-Montefiore scientists and clinicians are participating in nearly three dozen presentations, sessions and symposia during the five-day meeting. They will address a range of basic, translational and clinical research topics—from medication adherence in adolescents and the impact on resveratrol and vitamin D on insulin resistance to epigenetic ...

Designing ion 'highway systems' for batteries

2014-06-09

Since the early 1970s, lithium has been the most popular element for batteries: it's the lightest of all metals and has the greatest electrochemical potential. But a lithium-based battery has a major disadvantage: it's highly flammable, and when it overheats, it can burst into flames. For years, scientists have searched for safer battery materials that still have the same advantages as lithium. While plastics (or polymers) seemed like an obvious choice, researchers never fully understood how the material would change when an ion charge was introduced. Now a Northwestern ...

CU researchers explain mechanism that helps viruses spread

2014-06-09

AURORA, Colo. (June 9, 2014) – In an article published in the scientific journal Nature, a University of Colorado School of Medicine researcher and colleagues explain how RNA molecules found in certain viruses mimic the shape of other molecules as part of a strategy to 'hijack' the cell and make more viruses. The findings by Jeffrey S. Kieft, PhD, associate professor of biochemistry and molecular genetics at the School of Medicine and an early career scientist with the Howard Hughes Medical Institute, and his colleagues solve a biochemical and molecular mystery that has ...

LAST 30 PRESS RELEASES:

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce